Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
Background: To evaluate off-label and off-NCCN guidelines uses of antineoplastic drugs in a major Chinese hospital.Methods: Totally 1122 patients were selected from July to December 2011. Then, the off-label and off-NCCN guidelines uses of antineoplastic drugs were analyzed.Results: In 798 of 1122 p...
Saved in:
Main Authors: | Weilan Wang (Author), Man Zhu (Author), Daihong Guo (Author), Chao Chen (Author), Dongxiao Wang (Author), Fei Pei (Author), Liang Ma (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2013-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
by: Weilan Wang, et al.
Published: (2013) -
Guideline for the management of pediatric off-label use of drugs in China (2021)
by: Min Meng, et al.
Published: (2022) -
Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
by: Guangyao Li, et al.
Published: (2022) -
Recommendations on Off-Label Drug Use in Pediatric Guidelines
by: Min Meng, et al.
Published: (2022) -
Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis
by: Guoxu Wei, et al.
Published: (2021)